Home  >  Products  >  DLST (dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) ) Blocking Peptide (the C terminal of DLST)(100ug)
DLST (dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) ) Blocking Peptide (the C terminal of DLST)(100ug)

DLST (dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) ) Blocking Peptide (the C terminal of DLST)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DLST Antibody (ARP61476_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61476
Size: 100ug
Weight: 50kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The 2-oxoglutarate dehydrogenase complex catalyzes the overall conversion of 2-oxoglutarate to succinyl-CoA and CO2. It contains multiple copies of 3 enzymatic components: 2-oxoglutarate dehydrogenase (E1), dihydrolipoamide succinyltransferase (E2) and lipoamide dehydrogenase (E3).
Alternative names: DLTS
See Full Product Listings >